Lyophilization and development of solid protein pharmaceuticals

International Journal of Pharmaceutics

Volumn 203, Issue 1-2, 2000, Pages 1-60

  Wang, Wei ^a  

^a BAYER CORPORATION   (United States)

Author keywords

Aggregation; Cryoprotection; Denaturation; Excipient; Formulation; Freeze drying; Glass transition; Lyoprotection; Residual moisture; Stability

Indexed keywords

PROTEIN;

CRYOPROTECTION; DRUG FORMULATION; FREEZE DRYING; HUMIDITY; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DENATURATION; PROTEIN STABILITY; REVIEW; SOLID STATE;

CARBOHYDRATES; CHEMISTRY, PHARMACEUTICAL; FREEZE DRYING; HYDROGEN-ION CONCENTRATION; POLYMERS; PROTEIN DENATURATION; PROTEINS; TEMPERATURE;

EID: 0034255393     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00423-3     Document Type: Review

References (282)

1. Adams G.D.J., Ramsay J.R. Optimizing the lyophilization cycle and the consequences of collapse on the pharmaceutical acceptability of Erwinia L-asparaginase. J. Pharm. Sci. 85:1996;1301-1305.
2. Adler M., Lee G. Stability and surface activity of lactate dehydrogenase in spray-dried trehalose. J. Pharm. Sci. 88:1999;199-208.
3. Akers M.J., Milton N., Byrn S.R., Nail S.L. Glycine crystallization during freezing: the effect of salt form, pH, and ionic strength. Pharm. Res. 12:1995;1457-1461.
4. Aldén M., Magnusson A. Effect of temperature history on the freeze-thawing process and activity of LDH formulations. Pharm. Res. 14:1997;426-430.
5. Aldous B.J., Auffret A.D., Franks F. The crystallization of hydrate from amorphous carbohydrates. Cryo-Letters. 16:1995;181-186.
6. Allison S.D., Dong A., Carpenter J.F. Counteracting effects of thiocyanate and sucrose on chymotrypsinogen secondary structure and aggregation during freezing, drying and rehydration. Biophys. J. 71:1996;2022-2032.
7. Allison S.D., Randolph T.W., Manning M.C., Middleton K., Davis A., Carpenter J.F. Effects of drying methods and additives on structure and function of actin: mechanisms of dehydration-induced damage and its inhibition. Arch. Biochem. Biophy. 358:1998;171-181.
8. Allison S.D., Chang B., Randolph T.W., Carpenter J.F. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch. Biochem. Biophys. 365:1999;289-298.
9. Anchordoquy T.J., Carpenter J.F. Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state. Arch. Biochem. Biophys. 332:1996;231-238.
10. Andersson M.M., Hatti-Kaul R. Protein stabilizing effect of polyethyleneimine. J. Biotechnol. 72:1999;21-31.
11. Andya J.D., Maa Y.-F., Costantino H.R., Nguyen P.-A., Dasovich N., Sweeney T.D., Hsu C.C., Shire S.J. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Pharm. Res. 16:1999;350-358.
12. Angell C.A. Formation of glasses from liquid and biopolymers. Science. 267:1995;1924-1935.
13. Arakawa T., Yoshiko K., Carpenter J.F. Protein-solvent interactions in pharmaceutical formulations. Pharm. Res. 8:1991;285-291.
14. Arakawa T., Prestrelski S.J., Kenney W.C., Carpenter J.F. Factors affecting short-term and long-term stabilities of proteins. Adv. Drug Deliv. Rev. 10:1993;1-28.
15. Bam N.B., Randolph T.W., Cleland J.L. Stability of protein formulations: investigation of surfactant effects by a novel EPR spectroscopic technique. Pharm. Res. 12:1995;2-11.
16. Bell L.N., Hageman M.J., Muraoka L.M. Thermally induced denaturation of lyophilized bovine somatotropin and lysozyme as impacted by moisture and excipients. J. Pharm. Sci. 84:1995;707-712.
17. Bell L.N., Hageman M.J. Glass transition explanation for the effect of polyhydroxy compounds on protein denaturation in dehydrated solids. J. Food Sci. 61:1996;372-378.
18. Belton P.S., Gil A.M. IR and Raman spectroscopic studies of the interaction of trehalose with hen egg white lysozyme. Biopolymers. 34:1994;957-961.
19. Bindschaedler C. Lyophilization process validation. Rey L., May J.C. Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products. 96:1999;373-408 Marcel Dekker, New York.
20. Brange J., Havelund S., Hougaard P. Chemical stability of insulin. 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations. Pharm. Res. 9:1992a;727-734.
21. Brange J., Langkjær L., Havelund S., Vølund A. Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations. Pharm. Res. 9:1992b;715-726.
22. Breen E.D., Costantino H.R., Hsu C.C., Shire S.J. Affect of bulk concentration on reconstitution of lyophilized protein formulations. Pharm. Sci. 1((Suppl.)):1998;S540.
23. Buera M.D.P., Chirife J., Resnik S.L., Wetzler G. Nonenzymic browning in liquid model systems of high water activity: kinetics of color changes due to Maillard's reaction between different single sugars and glycine and comparison with caramelization browning. J. Food Sci. 52:1987;1063-1067.
24. Buera M.P., Levi G., Karel M. Glass transition in polyvinylpyrrolidone: effect of molecular weight and diluents. Biotechnol. Prog. 8:1992;144-148.
25. Bunk D.M. Characterization of the glycation of albumin in freeze-dried and frozen human serum. Anal. Chem. 69:1997;2457-2463.
26. Burke C.J., Steadman B.L., Volkin D.B., Tsai P.-K., Bruner M.W., Middaugh C.R. The adsorption of proteins to pharmaceutical container surfaces. Int. J. Pharm. 86:1992;89-93.
27. Bush L., Webb C., Bartlett L., Burnett B. The formulation of recombinant factor IX: stability, robustness, and convenience. Semin. Hematol. 35:1998;18-21.
28. Cardona S., Schebor C., Buera M.P., Karel M., Chirife J. Thermal stability of invertase in reduced-moisture amorphous matrices in relation to glassy state and trehalose crystallization. J. Food Sci. 62:1997;105-112.
29. Careri G., Giansanti A., Gratton E. Lysozyme film hydration events: an IR and gravimetric study. Biopolymers. 18:1979;1187-1203.
30. Carpenter J.F., Crowe J.H. An infrared spectroscopic study of the interactions of carbohydrates with dried proteins. Biochemistry. 28:1989;3916-3922.
31. Carpenter J.F., Hand S.C., Crowe L.M., Crowe J.H. Cryoprotection of phosphofructokinase with organic solutes: characterization of enhanced protection in the presence of divalent cations. Arch. Biochem. Biophys. 250:1986;505-512.
32. Carpenter J.F., Crowe L.M., Crowe J.H. Stabilization of phosphofructokinase with sugars during freeze-drying: characterization of enhanced protection in the presence of divalent cations. Biochim. Biophys. Acta. 923:1987;109-115.
33. Carpenter J.F., Crowe J.H., Arakawa T. Comparison of solute-induced protein stabilization in aqueous solution and in frozen and dried state. J. Dairy Sci. 73:1990;3627-3636.
34. Carpenter J.F., Arakawa T., Crowe J.H. Interactions of stabilizing additives with proteins during freeze-thawing and freeze-drying. Dev. Biol. Stand. 74:1991;225-239.
35. Carpenter J.F., Prestrelski S.J., Arakawa T. Separation of freezing and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzymatic activity and calorimetric studies. Arch. Biochem. Biophys. 303:1993;456-464.
36. Carpenter J.F., Pikal M.J., Chang B.S., Randolph T.W. Rational design of stable lyophilized protein formulations: some practical advice. Pharm. Res. 14:1997;969-975.
37. Carpenter J.F., Prestrelski S.J., Dong A. Application of infrared spectroscopy to development of stable lyophilized protein formulations. Eur. J. Pharm. Biopharm. 45:1998;231-238.
38. Carpenter J.F., Izutsu K., Randolph T.W. Freezing- and drying-induced perturbations of protein structure and mechanisms of protein protection by stabilizing additives. Rey L., May J.C. Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products. 96:1999;123-160 Marcel Dekker, New York.
39. Chan H.K., Gonda I. Solid state characterization of spray-dried powders of recombinant human deoxyribonuclease (rhDNase). J. Pharm. Sci. 87:1998;647-654.
40. Chan H.K., Au-Yeung K.L., Gonda I. Development of a mathematical model for the water distribution in freeze-dried solids. Pharm. Res. 16:1999;660-665.
41. Chang B.S., Randall C.S. Use of subambient thermal analysis to optimize protein lyophilization. Cryobiology. 29:1992;632-656.
42. Chang B.S., Randall C.S., Lee Y.S. Stabilization of lyophilized porcine pancreatic elastase. Pharm. Res. 10:1993;1478-1483.
43. Chang B.S., Fischer N.L. Development of an efficient single step freeze drying cycle for protein formulations. Pharm. Res. 12:1995;831-837.
44. Chang B.S., Beauvais R.M., Dong A., Carpenter J.F. Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation. Arch. Biochem. Biophys. 331:1996a;249-258.
45. Chang B.S., Kendrick B.S., Carpenter J.F. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J. Pharm. Sci. 85:1996b;1325-1330.
46. Chang B.S., Reeder G., Carpenter J.F. Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist. Pharm. Res. 13:1996c;243-249.
47. Chen B., Costantino H.R., Liu J., Hsu C.C., Shire S.J. Influence of calcium ions on the structure and stability of recombinant human deoxyribonuclease I in the aqueous and lyophilized states. J. Pharm. Sci. 88:1999;477-482.
48. Chuyen N.V. Maillard reaction and food processing. Application aspects. Adv. Exp. Med. Biol. 434:1998;213-235.
49. Cleland J.L., Powell M.F., Shire S.J. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Crit. Rev. Ther. Drug Carrier Syst. 10:1993;307-377.
50. Colaco C., Sen S., Thangavelu M., Pinder S., Roser B. Extraordinary stability of enzymes dried in trehalose: simplified molecular biology. Bio. Technol. 10:1992;1007-1011.
51. Cooper E.A., Knutson K. Fourier transform infrared spectroscopy investigations of protein structures. Herron J.N., Jiskoot W., Crommelin D.J.A. Physical Methods to Characterize Pharmaceutical Proteins. 1995;101-143 Plenum Press, New York.
52. Corveleyn S., De Smedt S., Remon J.P. Moisture absorption and desorption of different rubber lyophilization closures. Int. J. Pharm. 159:1997;57-65.
53. Costantino H.R., Langer R., Klibanov A.M. Solid-phase aggregation of proteins under pharmaceutically relevant conditions. J. Pharm. Sci. 83:1994a;1662-1669.
54. Costantino H.R., Langer R., Klibanov A.M. Moisture-induced aggregation of lyophilized insulin. Pharm. Res. 11:1994b;21-29.
55. Costantino H.R., Griebenow K., Mishra P., Langer R., Klibanov A.M. Fourier-transform infrared spectroscopic investigation of protein stability in the lyophilized form. Biochim. Biophy. Acta. 1253:1995a;69-74.
56. Costantino H.R., Langer R., Klibanov A.M. Aggregation of a lyophilized pharmaceutical protein, recombinant human albumin: effect of moisture and stabilization by excipients. Biotechnology. 13:1995b;493-496.
57. Costantino H.R., Schwendeman S.P., Griebenow K., Klibanov A.M., Langer R. The secondary structure and aggregation of lyophilized tetanus toxoid. J. Pharm. Sci. 85:1996;1290-1293.
58. Costantino H.R., Andya J.D., Nguyen P.-A., Dasovich N., Sweeney T.D., Shire S.J., Hsu C.C., Maa Y.-F. Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody. J. Pharm. Sci. 87:1998a;1406-1411.
59. Costantino H.R., Carrasquillo K.G., Cordero R.A., Mumenthaler M., Hsu C.C., Griebenow K. Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone. J. Pharm. Sci. 87:1998b;1412-1420.
60. Costantino H.R., Curley J.G., Wu S., Hsu C.C. Water sorption behavior of lyophilized protein-sugar systems and implications for solid-state interactions. Int. J. Pharm. 166:1998c;211-221.
61. Costantino H.R., Schwendeman S.P., Langer R., Klibanov A.M. Deterioration of lyophilized pharmaceutical proteins. Biochemistry (Moscow). 63:1998d;357-363.
62. Crowe J.H., Hoekstra F.A., Crowe L.M. Anhydrobiosis. Annu. Rev. Physiol. 54:1992;579-599.
63. Crowe J.H., Crowe L.M., Carpenter J.F. Preserving dry biomaterials: the water replacement hypothesis. Biopharm. 6(1):1993a;28-37.
64. Crowe J.H., Crowe L.M., Carpenter J.F. Preserving dry biomaterials: the water replacement hypothesis. Biopharm. 6(2):1993b;40-43.
65. Crowe L.M., Reid D.S., Crowe J.H. Is trehalose special for preserving dry biomaterials? Biophy. J. 71:1996;2087-2093.
66. Crowe J.H., Carpenter J.F., Crowe L.M. The role of vitrification in anhydrobiosis. Annu. Rev. Physiol. 60:1998;73-103.
67. Darcy P., Buckton G. The influence of heating/drying on the crystallization of amorphous lactose after structural collapse. Int. J. Pharm. 158:1997;157-164.
68. Daukas L.A., Trappler E.H. Assessing the quality of lyophilized parenterals. Pharm. Cosmetic Quality. 2:1998;21-25.
69. Dawson P.J. Effect of formulation and freeze-drying on the long-term stability of rDNA-derived cytokines. Dev. Biol. Stand. 74:1992;273-282.
70. DeGrazio F., Flynn K. Lyophilization closures for protein based drugs. J. Parenter. Sci. Technol. 46:1992;54-61.
71. De Young L.R., Dill K.A., Fink A.L. Aggregation and denaturation of apomyoglobin in aqueous urea solutions. Biochemistry. 32:1993;3877-3886.
72. Dill K.A., Alonso D.O.V., Hutchinson K. Thermal stabilities of globular proteins. Biochemistry. 28:1989;5439-5449.
73. Dill K.A. Dominant forces in protein folding. Biochemistry. 29:1990;7133-7155.
74. Dong A., Prestrelski S.J., Allison S.D., Carpenter J.F. Infrared spectroscopic studies of lyophilization- and temperature-induced protein aggregation. J. Pharm. Sci. 84:1995;415-423.
75. Duddu S.P., Dal Monte P.R. Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody. Pharm. Res. 14:1997;591-595.
76. Duddu S.P., Zhang G., Dal Monte P.R. The relationship between protein aggregation and molecular mobility below the glass transition temperature of lyophilized formulations containing a monoclonal antibody. Pharm. Res. 14:1997;596-600.
77. Eckhardt B.M., Oeswein J.Q., Bewley T.A. Effect of Freezing on aggregation of human growth hormone. Pharm. Res. 8:1991;1360-1364.
78. Fan J., Cooper E.I., Angell C.A. Glasses with strong calorimetric β-glass transitions and the relation to the protein glass transition problem. J. Phys. Chem. 98:1994;9345-9349.
79. Forbes R.T., Davis K.G., Hindle M., Clarke J.G., Maas J. Water vapor sorption studies on the physical stability of a series of spray-dried protein/sugar powders for inhalation. J. Pharm. Sci. 87:1998;1316-1321.
80. Ford A.W., Dawson P.J. Effect of type of container; storage temperature and humidity on the biological activity of freeze-dried alkaline phosphatase. Biologicals. 22:1994;191-197.
81. Fox K.C. Putting proteins under glass. Science. 267:1995;1922-1923.
82. Franks F. Freeze-drying: from empiricism to predictability. Cryo-Letters. 11:1990;93-110.
83. Franks F. Solid aqueous solutions. Pure Appl. Chem. 65:1993;2527-2537.
84. Franks F. Long-term stabilization of biologicals. Biotechnology. 12:1994;253-256.
85. Fransson J., Florin-Robertsson E., Axelsson K., Nyhlén C. Oxidation of human insulin-like growth factor I in formulation studies: kinetics of methionine oxidation in aqueous solution and in solid state. Pharm. Res. 13:1996;1252-1257.
86. French D.L., Arakawa T., Niven R.W., Li T. FTIR investigation of hydration-induced conformational changes in spray-dried protein/trehalose powders. Pharm. Res. 12 ((Suppl.)):1995;S83.
87. Getlin L.A. Kinetics of phase transitions in a frozen solution. Dev. Biol. Stand. 74:1991;93-104.
88. Gibson T.D. Protein stabilization using additives based on multiple electrostatic interactions. Dev. Biol. Stand. 87:1996;207-217.
89. 1. Pearlman R., Wang Y.J. Formulation, Characterization, and Stability of Protein Drugs. 1996;219-245 Plenum Press, New York.
90. Goormaghtigh E., Cabiaux V., Ruysschaert J.-M. Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy II. Experimental aspects, side chain structure, and H/D exchange. Subcell. Biochem. 23:1994;363-404.
91. Goto Y., Fink A.L. Conformational states of β-lactamase: molten-globule states at acidic and alkaline pH with high salt. Biochemistry. 28:1989;945-952.
92. Graziano G., Catanzano F., Riccio A., Barone G. A reassessment of the molecular origin of cold denaturation. J. Biochem. 122:1997;395-401.
93. Greiff D. Development of cycles for lyophilization. Dev. Biol. Stand. 74:1992;85-92.
94. Griebenow K., Klibanov A.M. Lyophilization-induced reversible changes in the secondary structure of proteins. Proc. Natl. Acad. Sci. USA. 92:1995;10969-10976.
95. Gu L.C., Erds E.A., Chiang H.-S., Calderwood T., Tsai K., Visor G.C., Duffy J., Hsu W.-C., Foster L.C. Stability of interleukin 1β(IL-1β) in aqueous solution: analytical methods, kinetics, products, and solution formulation implications. Pharm. Res. 8:1991;485-490.
96. Hageman M.J. The role of moisture in protein stability. Drug Dev. Ind. Pharm. 14:1988;2047-2069.
97. Hagen S.J., Hofrichter J., Eaton W.A. Protein reaction kinetics in a room-temperature glass. Science. 269:1995;959-962.
98. Hagen S.J., Hofrichter J., Eaton W.A. Germinate rebinding and conformational dynamics of myoglobin embedded in a glass at room temperature. J. Phys. Chem. 100:1996;12008-12021.
99. Hancock B.C., Zografi G. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm. Res. 11:1994;471-477.
100. Hancock B.C., Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86:1997;1-12.
101. Hancock B.C., Shamblin S.L., Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperature. Pharm. Res. 12:1995;799-806.
102. K) of amorphous pharmaceuticals. Pharm. Res. 15:1998;1649-1651.
103. Hartmann U., Bunner B., Körber C.H., Rau G. Where should be cooling rate be determined in an extended freezing sample. Cryobiology. 28:1991;115-130.
104. Hatley R.H. Glass fragility and the stability of pharmaceutical preparations-excipient selection. Pharm. Dev. Technol. 2:1997;257-264.
105. Hatley R.H.M., Franks F. Applications of DSC in the development of improved freeze-drying processes for labile biologicals. J. Therm. Anal. 37:1991;1905-1914.
106. Hatley R.H.M., Franks F., Brown S., Sandhu G., Gray M. Stabilization of a pharmaceutical drug substance by freeze-drying: a case study. Drug Stability. 1:1996;2-12.
107. Hekman C., Park S., Teng W.Y., Guzman N.A., Rossi T. Degradation of lyophilized and reconstituted Macroscint. J. Pharm. Biomed. Anal. 13:1995;1249-1261.
108. Heimburg T., Marsh D. Investigation of secondary and tertiary structural changes of cytochrome c in complexes with anionic lipids using amide hydrogen exchange measurements: an FTIR study. Biophys. J. 65:1993;2408-2417.
109. Heller M.C., Carpenter J.F., Randolph T.W. Manipulation of lyophilization-induced phase separation: implications for pharmaceutical proteins. Biotechnol. Prog. 13:1997;590-596.
110. Heller M.C., Carpenter J.F., Randolph T.W. Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation. Biotechnol. Bioeng. 63:1999a;166-174.
111. Heller M.C., Carpenter J.F., Randolph T.W. Conformational stability of lyophilized PEGylated proteins in a phase-separating system. J. Pharm. Sci. 88:1999b;58-64.
112. Heller M.C., Carpenter J.F., Randolph T.W. Application of a thermodynamic model to the prediction of phase separations in freeze-concentrated formulations for protein lyophilization. Arch. Biochem. Biophys. 363:1999c;191-201.
113. Her L.-M., Nail S.L. Measurement of glass transition temperatures of freeze-concentrated solutes by differential scanning calorimetry. Pharm. Res. 11:1994;54-59.
114. Hora M.S., Rana R.K., Smith F.W. Lyophilized formulations of recombinant tumor necrosis factor. Pharm. Res. 9:1992a;33-36.
115. Hora M.S., Rana R.K., Wilcox C.L., Katre N.V., Hirtzer P., Wolfe S.N., Thomson J.W. Development of a lyophilized formulation of interleukin-2. Dev Biol Stand. 74:1992b;295-303.
116. House J.A., Mariner J.C. Stabilization of rinderpest vaccine by modification of the lyophilization process. Dev. Biol. Stand. 87:1996;235-244.
117. Hsu C.C., Ward C.A., Pearlman R., Nguyen H.M., Yeung D.A., Curley J.G. Determining the optimum residual moisture in lyophilized protein pharmaceuticals. Dev. Biol. Stand. 74:1991;255-271.
118. Hsu C.C., Nguyen H.M., Yeung D.A., Brookes D.A., Koe G.S., Bewley T.A., Pearlman R. Surface denaturation at solid-void interface - a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures. Pharm. Res. 12:1995;69-77.
119. Hsu C.C., Walsh A.J., Nguyen H.M., Overcashier D.E., Koning-Bastiaan H., Bailey R.C., Nail S.L. Design and application of a low-temperature Peltier-cooling microscope stage. J. Pharm. Sci. 85:1996;70-74.
120. Izutsu K., Yoshioka S., Terao T. Decreased protein-stabilizing effects of cryoprotectants due to crystallization. Pharm. Res. 10:1993;1232-1237.
121. Izutsu K., Yoshioka S., Kojima S. Physical stability and protein stability of freeze-dried cakes during storage at elevated temperatures. Pharm. Res. 11:1994a;995-999.
122. Izutsu K., Yoshioka S., Terao T. Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying. Chem. Pharm. Bull. (Tokyo). 42:1994b;5-8.
123. Izutsu K., Yoshioka S., Kojima S. Increased stabilizing effects of amphiphilic excipients on freeze-drying of lactate dehydrogenase (LDH) by dispersion into sugar matrices. Pharm. Res. 12:1995;838-843.
124. Izutsu K., Yoshioka S., Kojima S., Randolph T.W., Carpenter J.F. Effects of sugars and polymers on crystallization of poly(ethylene glycol) in frozen solutions: phase separation between incompatible polymers. Pharm. Res. 13:1996;1393-1400.
125. Jaenicke R. Protein structure and function at low temperatures. Philos. Trans. R. Soc. Lond. B Biol. Sci. 326:1990;535-551.
126. Jennings T.A. Lyophilization: Introduction and Basic Principles. 1999;Interpharm Press, Colorado, USA.
127. Jennings T.A., Duan N. Calorimetric monitoring of lyophilization. J. Parent. Sci. Technol. 49:1995;272-282.
128. Jordan G.M., Yoshioka S., Terao T. The aggregation of bovine serum albumin in solution and in the solid state. J. Pharm. Pharmacol. 46:1994;182-185.
129. Kasraian K., Spitznagel T.M., Juneau J.A., Yim K. Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy. Pharm. Dev. Technol. 3:1998;233-239.
130. Katakam M., Banga A.K. Aggregation of insulin and its prevention by carbohydrate excipients. PDA J. Pharm. Sci. Technol. 49:1995;160-165.
131. Katakam M., Robillard P., Brown J., Tolman G. Effects of moisture and lyophilization cycle on aggregation of a monoclonal antibody product. Pharm. Sci. 1((Suppl.)):1998;S543.
132. Kendrick B., Chang B.S., Dong A., Kreilgård L., Carpenter J.F. An infrared spectroscopic study on the structural changes induced by cooling and freezing stresses on proteins. Pharm. Res. 12((Suppl.)):1995a;84.
133. Kendrick, B., Chang, B.Y., Carpenter, J.F., 1995b. Detergent stabilization of proteins against surface and freezing denaturation. Pharm. Res., 12 (Supple), S-85.
134. Kendrick B.S., Dong A., Allison S.D., Manning M.C., Carpenter J.F. Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states. J. Pharm. Sci. 85:1996;155-158.
135. Kenney W.C., Watson E., Bartley T., Boone T., Altrock B.W. Parameters for the evaluation of IL-2 stability. Lymphokine Res. 5((Suppl. 1)):1986;S23-S27.
136. Kerr W.L., Lim M.H., Reid D.S., Chen H. Chemical reaction kinetics in relation to glass transition temperature in frozen food polymer solutions. J. Sci. Food Agric. 61:1993;51-56.
137. Kerwin B.A., Heller M.C., Levin S.H., Randolph T.W. Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20°C of a recombinant hemoglobin. J. Pharm. Sci. 87:1998;1062-1068.
138. Kim A.I., Akers M.J., Nail S.L. The physical state of mannitol after freeze-drying: effect of mannitol concentration, freezing rate, and a noncrystallizing cosolute. J. Pharm. Sci. 87:1998;931-935.
139. Koseki T., Kitabatake N., Doi E. Freezing denaturation of ovalbumin at acid pH. J. Biochem. 107:1990;389-394.
140. Kreilgaard L., Frokjaer S., Flink J.M., Randolph T.W. Carpenter JF Effects of additives on the stability of recombinant human factor XIII during freeze-drying and storage in the dried solid. Arch. Biochem. Biophys. 360:1998a;121-134.
141. Kreilgaard L., Jones L.S., Randolph T.W., Frokjaer S., Flink J.M., Manning M.C., Carpenter J.F. Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. J. Pharm. Sci. 87:1998b;1597-1603.
142. Kreilgaard L., Frokjaer S., Flink J.M., Randolph T.W., Carpenter J.F. Effects of additives on the stability of Humicola lanuginosa lipase during freeze-drying and storage in the dried solid. J. Pharm. Sci. 88:1999;281-290.
143. Kristjánsson M.M., Kinsella J.E. Protein and enzyme stability: structural, thermodynamic, and experimental aspects. Adv. Food Nutr. Res. 35:1991;237-316.
144. Kuhlman B., Yang H.Y., Boice J.A., Fairman R., Raleigh D.P. An exceptionally stable helix from the ribosomal protein L9: Implications for protein folding and stability. J. Mol. Biol. 270:1997;640-647.
145. Lai M.C., Topp E.M. Solid-state chemical stability of proteins and peptides. J. Pharm. Sci. 88:1999;489-500.
146. Lam X.M., Costantino H.R., Overcashier D.E., Nguyen T.H., Hsu C.C. Replacing succinate with glycocholate buffer improves the stability of lyophilized interferon-γ Int. J. Pharm. 142:1996;85-95.
147. Leslie S.B., Israeli E., Lighthart B., Crowe J.H., Crowe L.M. Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying. Appl. Environ. Microbiol. 61:1995;3592-3597.
148. Levine H., Slade L. Another view of trehalose for drying and stabilizing biological materials. Biopharm. 5(5):1992;36-40.
149. Li S., Nguyen T., Schöneich C., Borchardt R.T. Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry. 34:1995a;5762-5772.
150. Li S., Schöneich C., Borchardt R.T. Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization. Biotechnol. Bioeng. 48:1995b;491-500.
151. Li S., Patapoff T.W., Overcashier D., Hsu C., Nguyen T.H., Borchardt R.T. Effects of reducing sugars on the chemical stability of human relaxin in the lyophilized state. J. Pharm. Sci. 85:1996;873-877.
152. Librizzi F., Vitrano E., Cordone L. Dehydration and crystallization of trehalose and sucrose glasses containing carbonmonoxy-myoglobin. Biophys. J. 76:1999;2727-2734.
153. Lin T.-Y., Timasheff S.N. On the role of surface tension in the stabilization of globular proteins. Protein Sci. 5:1996;372-381.
154. Lin L.S., Kunitani M.G., Hora M.S. Interferon-β-1b (Betaseron®): a model for hydrophobic therapeutic proteins. Pearlman R., Wang Y.J. Formulation, Characterization, and Stability of Protein Drugs. 1996;275-301 Plenum Press, New York.
155. Liu R., Orgel L. Efficient oligomerization of negatively charged Beta-amino acids at -20°C. J. Am. Chem. Soc. 119:1997;9192.
156. Liu W.R., Langer R., Klibanov A.M. Moisture-induced aggregation of lyophilized proteins in the solid state. Biotechnol. Bioeng. 37:1990;177-184.
157. Liu J.L., Lu K.V., Eris T., Katta V., Westcott K.R., Narhi L.O., Lu H.S. In vitro methionine oxidation of recombinant human leptin. Pharm. Res. 15:1998;632-640.
158. Lu Q., Zografi G. Properties of citric acid at the glass transition. J. Pharm. Sci. 86:1997;1374-1378.
159. Lueckel B., Bodmer D., Helk B., Leuenberger H. Formulations of sugars with amino acids or mannitol-influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate. Pharm. Dev. Technol. 3:1998a;325-336.
160. Lueckel B., Helk B., Bodmer D., Leuenberger H. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage. Pharm. Dev. Technol. 3:1998b;337-346.
161. Ma X., Wang D.Q., Bouffard R., MacKenzie A. Characterization of protein formulation for freeze-drying cycle development. Pharm. Sci. 1((Suppl.)):1998;S543.
162. Manning M.C., Patel K., Borchardt R.T. Stability of protein pharmaceuticals. Pharm. Res. 6:1989;903-917.
163. Mattern M., Winter G., Rudolph R., Kohnert U., Lee G. Formulation of proteins in vacuum-dried glasses. I. Improved vacuum drying using crystallizing amino acids. Eur. J. Pharm. Biopharm. 44:1997;177-185.
164. Mattern M., Winter G., Kohnert U., Lee G. Formulation of proteins in vacuum-dried glasses. II. Process and storage stability in sugar-free amino acid systems. Pharm. Dev. Technol. 4:1999;199-208.
165. May J.C., Wheeler R.M., Grim E. The gravimetric method for the determination of residual moisture in freeze-dried biological products. Cryobiology. 26:1989;277-284.
166. Mazzobre M.F., Buera M.P., Chirife J. Glass transition and thermal stability of lactase in low-moisture amorphous polymeric matrices. Biotechnol. Prog. 13:1997;195-199.
167. Meredith P., Donald A.M., Payne R.S. Freeze-drying: in situ observations using cryoenviromental scanning electron microscopy and differential scanning calorimetry. J. Pharm. Sci. 85:1996;631-637.
168. Miller D.P., de Pablo J.J., Corti H. Thermophysical properties of trehalose and its concentrated aqueous solutions. Pharm. Res. 14:1997;578-590.
169. Moreira T., Pendas J., Gutierrez A., Pomes R., Duque J., Franks F. Effect of sucrose and raffinose on physical state and on lactate dehydrogenase activity of freeze-dried formulations. Cryo-Letters. 19:1998;115-122.
170. Mozhaev V.V., Martinek K. Structure-stability relationships in proteins: new approaches to stabilizing enzymes. Enzyme Microb. Technol. 6:1984;50-59.
171. Nail S.L., Johnson W. Methodology for in-process determination of residual water in freeze-dried products. Dev. Biol. Stand. 74:1992;137-150.
172. Nagendra H.G., Sukumar N., Vijayan M. Role of water in plasticity, stability, and action of proteins: the crystal structures of lysozyme at very low levels of hydration. Proteins: Struct. Func. Gen. 32:1998;229-240.
173. Naini V., Byron P.R., Phillips E.M. Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers. Drug Dev. Ind. Pharm. 24:1998;895-909.
174. Nakai Y., Yoshioka S., Aso Y., Kojima S. Solid-state rehydration-induced recovery of bilirubin oxidase activity in lyophilized formulations reduced during freeze-drying. Chem. Pharm. Bull. 46:1998;1031-1033.
175. Nayar, R., 1998. Stabilized albumin-free recombinant factor VIII having a low sugar content. US patent #5763401.
176. Nema S., Avis K.E. Freeze-thaw studies of a model protein, lactate dehydrogenase, in the presence of cryoprotectants. J. Parenter. Sci. Technol. 47:1992;76-83.
177. Nguyen T.H., Burnier J., Meng W. The kinetics of relaxin oxidation by hydrogen peroxide. Pharm. Res. 10:1993;1563-1571.
178. O'Brien J. Stability of trehalose, sucrose and glucose to nonenzymatic browning in model systems. J. Food Sci. 61:1996;679-682.
179. Oetjen G.-W. Industrial freeze-drying for pharmaceutical applications. Rey L., May J.C. Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products. 96:1999;267-335 Marcel Dekker, New York.
180. Oksanen C.A., Zografi G. The relationship between the glass transition temperature and water vapor absorption by poly(vinylpyrrolidone). Pharm. Res. 7:1990;654-657.
181. Oksanen C.A., Zografi G. Molecular mobility in mixtures of absorbed water and solid poly(vinylpyrrolidone). Pharm. Res. 10:1993;791-799.
182. Österberg T., Wadsten T. Physical state of L-histidine after freeze-drying and long-term storage. Eur. J. Pharm. Sci. 8:1999;301-308.
183. Österberg T., Fatouros A., Mikaelsson M. Development of freeze-dried albumin-free formulation of recombinant factor VIII SQ. Pharm. Res. 14:1997;892-898.
184. Overcashier D.E., Brooks D.A., Costantino H.R., Hsu C.C. Preparation of excipient-free recombinant human tissue-type plasminogen activator by lyophilization from ammonium bicarbonate solution: An investigation of the two-stage sublimation phenomenon. J. Pharm. Sci. 86:1997;455-459.
185. Overcashier D.E., Patapoff T.W., Hsu C.C. Lyophilization of protein formulations in vials: investigation of the relationship between resistance to vapor flow during primary drying and small-scale product collapse. J. Pharm. Sci. 88:1999;688-695.
186. Paulsen H., Pflughaupt K.-W. Glycosylamines. Pigman W., Horton D., Wander J.D. The Carbohydrates Chemistry and Biochemistry. 1980;881-921 Academic Press, New York.
187. Pearson D.S., Smith G. Dielectric analysis as a tool for investigating the lyophilization of proteins. Pharm. Sci. Technol. Today. 1:1998;108-117.
188. Perlman R., Nguyen T. Pharmaceutics of protein drugs. J. Pharm. Pharmcol. 44((Suppl. 1)):1992;178-185.
189. Physicians Desk Reference, 1999. Medical Economics Company Incorporation, 53rd edn. Montvale, NJ.
190. Pikal M.J. Freeze-drying of proteins. Part I: process design. Biopharm. 3(8):1990a;18-27.
191. Pikal M.J. Freeze-drying of proteins. Part II: formulation selection. Biopharm. 3(9):1990b;26-30.
192. Pikal M.J. Mechanisms of protein stabilization during freeze-drying and storage: the relative importance of thermodynamic stabilization and glassy state relaxation dynamics. Rey L., May J.C. Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products. 96:1999;161-198 Marcel Dekker, New York.
193. Pikal M.J., Rigsbee D.R. The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form. Pharm. Res. 14:1997;1379-1387.
194. Pikal M.J., Shah S. Intravial distribution of moisture during the secondary drying stage of freeze drying. PDA J. Pharm. Sci. Technol. 51:1997;17-24.
195. Pikal K.A., Carpenter J.F. pH changes during freezing in sodium and potassium phosphate buffer systems in the presence of glycine: effect on protein stability. Pharm. Sci. 1((Suppl.)):1998;544.
196. Pikal M.J., Dellerman K.M., Roy M.L., Riggin R.M. The effects of formulation variables on the stability of freeze-dried human growth hormone. Pharm. Res. 8:1991;427-436.
197. Pikal M.J., Dellerman K., Roy M.L. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. Dev. Biol. Stand. 74:1992;21-37.
198. Prestrelski S.J., Arakawa T., Carpenter J.F. Separation of freezing and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. II. Structural studies using infrared spectroscopy. Arch. Biochem. Biophys. 303:1993a;465-473.
199. Prestrelski S.J., Tedeschi N., Arakawa T., Carpenter J.F. Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophy. J. 65:1993b;661-671.
200. Prestrelski S.J., Pikal K.A., Arakawa T. Optimization of lyophilization conditions for recombinant human interleukin-2 by dried-state conformational analysis using Fourier-transform infrared spectroscopy. Pharm. Res. 12:1995;1250-1259.
201. Ramos A., Raven N.D.H., Sharp R.J., Bartolucci S., Roswsi M., Cannio R., Lebbink J., vanderOost J., deVos W.M., Santos H. Stabilization of enzymes against thermal stress and freeze-drying by mannosylglycerate. Appl. Environ. Microbiol. 63:1997;4020-4025.
202. Ravve, A., 1967. Physical properties of macromolecules. Chapter 2 in Organic Chemistry of Macromolecules,@ Marcel Dekker, New York. pp. 17-36.
203. Remmele R.L. Jr, Stushnoff C., Carpenter J.F. Real-time in situ monitoring of lysozyme during lyophilization using infrared spectroscopy: dehydration stress in the presence of sucrose. Pharm. Res. 14:1997;1548-1555.
204. Ressing M.E., Jiskoot W., Talsma H., van Ingen C.W., Beuvery E.C., Crommelin D.J. The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12). Pharm. Res. 9:1992;266-270.
205. Rey L. Glimpses into the realm of freeze-drying: classical issues and new ventures. Rey L., May J.C. Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products. 96:1999;1-30 Marcel Dekker, New York.
206. Reyes F.G.R., Poocharoen B., Wrolstad R.E. Maillard browning reaction of sugar-glycine model systems: changes in sugar concentration, color and appearance. J. Food Sci. 47:1982;1376-1377.
207. Rossi S., Buera M.P., Moreno S., Chirife J. Stabilization of the restriction enzyme EcoRI dried with trehalose and other selected glass-forming solutes. Biotechnol. Prog. 13:1997;609-616.
208. Roy M.L., Pikal M.J., Rickard E.C., Maloney A.M. The effects of formulation and moisture on the stability of a freeze-dried monoclonal antibody-vinca conjugate: a test of the WLF glass transition theory. Dev. Biol. Stand. 74:1992;323-339.
209. Rupley J.A., Careri G. Protein hydration and function. Adv. Protein Chem. 41:1991;37-173.
210. Roos Y. Melting and glass transitions of low molecular weight carbohydrates. Carbohydr. Res. 238:1993;39-48.
211. Roos Y., Karel M. Phase transitions of mixtures of amorphous polysaccharides and sugars. Biotechnol. Prog. 7:1991;49-53.
212. Roser B. Trehalose drying: a novel replacement for freeze-drying. Biopharm. 4(9):1991;47-53.
213. Ruddon R.W., Bedows E. Assisted protein folding. J. Biol. Chem. 272:1997;3125.
214. Sampedro J.G., Guerra G., Pardo J.P., Uribe S. Trehalose-mediated protection of the plasma membrane H+-ATPase from Kluyveromyces lactis during freeze-drying and rehydration. Cryobiology. 37:1998;131-138.
215. Sarciaux J.M., Hageman M.J. Effects of bovine somatotropin (rbSt) concentration at different moisture levels on the physical stability of sucrose in freeze-dried rbSt/sucrose mixtures. J. Pharm. Sci. 86:1997;365-371.
216. Sarciaux J.-M., Mansour S., Hageman M.J., Nail S.L. Effect of species, processing conditions and phosphate buffer composition on IgG aggregation during lyophilization. Pharm. Sci. 1((Suppl.)):1998;545.
217. Sasaoki K., Hiroshima T., Kusumoto S., Nishu K. Deamidation at asparagine-88 in recombinant human interleukin 2. Chem. Pharm. Bull. (Tokyo). 40:1992;976-980.
218. Sartor G., Mayer E., Johari G.P. Calorimetric studies of the kinetic unfreezing of molecular motions in hydrated lysozyme, hemoglobin, and myoglobin. Biophys. J. 66:1994;249-258.
219. Sastry G.M., Agmon N. Trehalose prevents myoglobin collapse and preserves its internal mobility. Biochemistry. 36:1997;7097-7108.
220. Savage M., Torres J., Franks L., Masecar B., Hotta J. Determination of adequate moisture content for efficient dry-heat viral inactivation in lyophilized factor VIII by loss on drying and by near infrared spectroscopy. Biologicals. 26:1998;119-124.
221. Schebor C., Buera M.P., Chirife J. Glassy state in relation to the thermal inactivation of enzyme invertase in amorphous dried matrices of trehalose, maltodextrin and PVP. J. Food Eng. 30:1996;269-282.
222. Schebor C., Burin L., Buera M.P., Aguilera J.M., Chirife J. Glassy state and thermal inactivation of invertase and lactase in dried amorphous matrices. Biotechnol. Prog. 13:1997;857-863.
223. Schmitt E.A., Law D., Zhang G.G.Z. Nucleation and crystallization kinetics of hydrated amorphous lactose above glass transition temperature. J. Pharm. Sci. 88:1999;291-296.
224. Schwendeman S.P., Costantino H.R., Gupta R.K., Siber G.R., Klibanov A.M., Langer R. Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation. Proc. Natl. Acad. Sci. USA. 92:1995;11234-11238.
225. Schwendeman S.P., Costantino H.R., Gupta R.K., Tobio M., Chang A.C., Alonso M.J., Siber G.R., Langer R. Strategies for stabilizing tetanus toxoid towards the development of a single-dose tetanus vaccine. Dev. Biol. Stand. 87:1996;293-306.
226. Separovic F., Lam Y.H., Ke X., Chan H.K. A solid-state NMR study of protein hydration and stability. Pharm. Res. 15:1998;1816-1821.
227. Shalaev E.Y., Zografi G. How does residual water affect the solid-state degradation of drugs in the amorphous state? J. Pharm. Sci. 85:1996;1137-1141.
228. Shamblin S.L., Zografi G. The effects of absorbed water on the properties of amorphous mixtures containing sucrose. Pharm. Res. 16:1999;1119-1124.
229. Shamblin S.L., Huang E.Y., Zografi G. The effects of colyophilized polymeric additives on the glass transition temperature and crystallization of amorphous sucrose. J. Therm. Anal. 47:1996;1567-1579.
230. Shamblin S.L., Hancock B.C., Zografi G. Water vapor sorption by peptides, proteins and their formulations. Eur. J. Pharm. Biopharm. 45:1998;239-247.
231. Sheehan P., Liapis A.I. Modeling of the primary and secondary drying stages of the freeze drying of pharmaceutical products in vials: numerical results obtained from the solution of a dynamic and spatially multi-dimensional lyophilization model for different operational policies. Biotechnol. Bioeng. 60:1998;712-728.
232. Shikama K., Yamazaki I. Denaturation of catalase by freezing and thawing. Nature. 190:1961;83-84.
233. Shortle D. The denatured state (the other half of the folding equation) and its role in protein stability. FASEB J. 10:1996;27-34.
234. Skrabanja A.T., de Meere A.L., de Ruiter R.A., van den Oetelaar P.J. Lyophilization of biotechnology products. PDA J. Pharm. Sci. Technol. 48:1994;311-317.
235. Slade L., Levine H., Finley J.W. Protein-water interactions: water as a plasticizer of gluten and other protein polymers. Philips R.D., Finley J.W. Protein Quality and the Effects of Processing. 1989;9-124 Marcel Dekker, New York.
236. Sola-Penna M., Meyer-Fernandes J.R. Stabilization against thermal inactivation promoted by sugars on enzyme structure and function: why is trehalose more effective than other sugars? Arch. Biochem. Biophys. 360:1998;10-14.
237. Strambini G.B., Gabellieri E. Proteins in frozen solutions: evidence of ice-induced partial unfolding. Biophys. J. 70:1996;971-976.
238. Strickley R.G., Anderson B.D. Solid-state stability of human insulin I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions. Pharm. Res. 13:1996;1142-1153.
239. Strickley R.G., Anderson B.D. Solid-state stability of human insulin I. Effect of water on reactive intermediate partitioning in lyophiles from pH 2-5 solutions: stabilization against covalent dimer formation. J. Pharm. Sci. 86:1997;645-653.
240. Sun W.Q. Temperature and viscosity for structural collapse and crystallization of amorphous carbohydrate solutions. Cryo-Letters. 18:1997;99-106.
241. Sun W.Q., Davidson P. Protein inactivation in amorphous sucrose and trehalose matrices: effects of phase separation and crystallization. Biochim. Biophys Acta. 1425:1998;235-244.
242. Sun W.Q., Davidson P., Chan H.S.O. Protein stability in the amorphous carbohydrate matrix: relevance to anhydrobiosis. Biochim. Biophy. Acta. 1425:1998;245-254.
243. Susi H., Byler D.M. Resolution-enhanced Fourier transform infrared spectroscopy of enzymes. Methods Enzymol. 130:1986;290-311.
244. Tanaka K., Takeda T., Miyajima K. Cryoprotective effect of saccharides on denaturation of catalase by freeze-drying. Chem. Pharm. Bull. 39:1991;1091-1094.
245. Tarelli E., Mire-Sluis A., Tivnann H.A., Bolgiano B., Crane D.T., Gee C., Lemercinier X., Athayde M.L., Sutcliffe N., Corran P.H., Rafferty B. Recombinant human albumin as a stabilizer for biological materials and for the preparation of international reference reagents. Biologicals. 26:1998;331-346.
246. Taylor L.S., Zografi G. The quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharm. Res. 15:1998a;755-761.
247. Taylor L.S., Zografi G. Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures. J. Pharm. Sci. 87:1998b;1615-1621.
248. te Booy M.P., de Ruiter R.A., de Meere A.L. Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry. Pharm. Res. 9:1992;109-114.
249. Timasheff S.N. The control of protein stability and association by weak interactions with water: how do solvents affect these processes? Annu. Rev. Biophy. Biomol. Struct. 22:1993;67-97.
250. Timasheff S.N. Control of protein stability and reactions by weakly interacting cosolvents: the simplicity of the complicated. Adv. Protein Chem. 51:1998;355-432.
251. Towns J.K. Moisture content in proteins: its effects and measurement. J. Chromatogr. A705:1995;115-127.
252. Townsend M.W., DeLuca P.P. Stability of ribonuclease A in solution and the freeze-dried state. J. Pharm. Sci. 79:1990;1083-1086.
253. Tsai A.M., van Zanten J.H., Betenbaugh M.J. I. Study of protein aggregation due to heat denaturation: a structural approach using circular dichroism spectroscopy, nuclear magnetic resonance, and static light scattering. Biotechnol. Bioeng. 59:1998;273-280.
254. Tzannis S.T., Prestrelski S.J. Activity-stability considerations of trypsinogen during spray drying: effects of sucrose. J. Pharm. Sci. 88:1999a;351-359.
255. Tzannis S.T., Prestrelski S.J. Moisture effects on protein-excipient interactions in spray-dried powders. Nature of destabilizing effects of sucrose. J. Pharm. Sci. 88:1999b;360-370.
256. Uritani M., Takai M., Yoshinaga K. Protective effect of disaccharides on restriction endonucleases during drying under vacuum. J. Biochem. (Tokyo). 117:1995;774-779.
257. Vemuri S., Yu C.D., Roosdorp N. Effect of cryoprotectants on freezing, lyophilization, and storage of lyophilized recombinant alpha 1-antitrypsin formulations. PDA J. Pharm. Sci. Technol. 48:1994;241-246.
258. Volkin D.B., Klibanov A.M. Minimizing protein inactivation. Creighton T.E. Protein Function A Practical Approach. 1989;1-24 Information Press, Oxford, UK.
259. Volkin D.B., Middaugh C.R. The characterization, stabilization, and formulation of acidic fibroblast growth factor. Pearlman R., Wang Y.J. Formulation, Characterization, and Stability of Protein Drugs. 1996;181-217 Plenum Press, New York.
260. Vrkljan M., Foster T.M., Powers M.E., Henkin J., Porter W.R., Staack H., Carpenter J.F., Manning M.C. Thermal stability of low molecular weight urokinase during heat treatment. Effect of polymeric additives. Pharm. Res. 11(2):1994;1004-1008.
261. Wang W. Oral protein drug delivery. J. Drug Target. 4:1996;195-232.
262. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 185:1999;129-188.
263. Wang Y.J., Chen H., Busch M., Baldwin P.A. Headspace analysis for parenteral products: oxygen permeation and integrity test. Pharm. Technol. 21:1997;108-122.
264. Ward K.R., Adams G.D., Alpar H.O., Irwin W.J. Protection of the enzyme L-asparaginase during lyophilisation - a molecular modelling approach to predict required level of lyoprotectant. Int. J. Pharm. 187:1999;153-162.
265. Webb S., Randolph T., Carpenter J., Cleland J. An investigation into reconstitution of lyophilized recombinant human interferon-gamma. Pharm. Sci. 1((Suppl.)):1998;542.
266. Willemer H. Measurements of temperatures, ice evaporation rates and residual moisture contents in freeze-drying. Dev. Biol. Stand. 74:1992;123-134.
267. Willemer H. Experimental freeze-drying: procedures and equipment. Rey L., May J.C. Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products. 96:1999;79-121 Marcel Dekker, New York.
268. Wisniewski R. Developing large-scale cryopreservation systems for biopharmaceutical products. Biopharm. 11:1998;50-60.
269. Wolkers W.F., Oldenhof H., Alberda M., Hoekstra F.A. A Fourier transform infrared microspectroscopy study of sugar glasses: application to anhydrobiotic higher plant cells. Biochim. Biophys. Acta. 1379:1998a;83-96.
270. Wolkers W.F., van Kilsdonk M.G., Hoekstra F.A. Dehydration-induced conformational changes of poly-L-lysine as influenced by drying rate and carbohydrates. Biochim. Biophys. Acta. 1425:1998b;127-136.
271. Wong D., Parascrampuria J. Pharmaceutical excipients for the stabilization of proteins. Pharm. Technol. 21:1997;34-50.
272. Wu S., Leung D., Vemuri S., Shah D., Yang B., Wang J. Degradation mechanism of lyophilized basic fibroblast growth factor (BFGF) protein in sugar formulation. Pharm. Sci. 1((Suppl.)):1998;S-539.
273. Yang T.-H., Dong A., Meyer J., Johnson O.L., Cleland J.L., Carpenter J.F. Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. J. Pharm. Sci. 88:1999;161-165.
274. Yeo S.-D., Debenedetti P.G., Patro S.Y., Przybycien T.M. Secondary structure characterization of microparticulate insulin powders. J. Pharm. Sci. 83:1994;1651-1656.
275. Yoshioka S., Aso Y., Izutsu K., Terao T. Aggregates formed during storage of β-galactosidase in solution and in the freeze-dried state. Pharm. Res. 10:1993;103-108.
276. Yoshioka S., Aso Y., Izutsu K.-I., Terao T. Application of accelerated testing for shelf-life prediction of commercial protein preparations. J. Pharm. Sci. 83:1994;454-456.
277. Yoshioka S., Aso Y., Kojima S. Dependence of the molecular mobility and protein stability of freeze-dried γ-globulin formulations on the molecular weight of dextran. Pharm. Res. 14:1997;736-741.
278. Yoshioka S., Aso Y., Nakai Y., Kojima S. Effect of high molecular mobility of poly(vinyl alcohol) on protein stability of lyophilized γ-globulin formulations. J. Pharm. Sci. 87:1998;147-151.
279. Yoshioka S., Aso Y., Kojima S. The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature. Pharm. Res. 16:1999;135-140.
280. Yu L., Milton N., Groleau E.G., Mishra D.S., Vansickle R.E. Existence of a mannitol hydrate during freeze-drying and practical implications. J. Pharm. Sci. 88:1999;196-198.
281. Zhang M.Z., Wen J., Arakawa T., Prestrelski S.J. A new strategy for enhancing the stability of lyophilized protein: the effect of the reconstitution medium on keratinocyte growth factor. Pharm. Res. 12:1995;1447-1452.
282. Zhang M.Z., Pikal K., Nguyen T., Arakawa T., Prestrelski S.J. The effect of the reconstitution medium on aggregation of lyophilized recombinant interleukin-2 and ribonuclease A. Pharm. Res. 13:1996;643-646.